1.305

1.95% 0.025

Novabridge Biosciences Adr (NBP)

Overview News Price History Option Chain Financials Discussions Forecast

Novabridge Biosciences Adr stock is traded at $1.305, with a volume of 374.38K. It is up +1.95% in the last 24 hours and down -17.92% over the past month. NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Previous Close:

$1.28

Open:

$1.29

24h Volume:

374.38K

Relative Volume:

1.08

Market Cap:

$150.92M

Revenue:

$232.79M

Net Income/Loss:

$-88.69M

P/E Ratio:

-2.9532

EPS:

-0.4419

Net Cash Flow:

1W Performance:

-4.74%

1M Performance:

-17.92%

6M Performance:

-49.81%

1Y Performance:

+0.00%

1-Day Range:

$1.29

$1.32

1-Week Range:

$1.26

$1.4188

52-Week Range:

$1.26

$5.19

Novabridge Biosciences Adr Stock (NBP) Company Profile

Name

Novabridge Biosciences Adr

Sector

Healthcare (1051)

Industry

Biotechnology (593)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

NBP's Discussions on Twitter

Compare NBP vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NBP Novabridge Biosciences Adr	1.305	150.92M	232.79M	-88.69M	0	-0.4419
VRTX Vertex Pharmaceuticals Inc	508.74	128.95B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	236.50	94.42B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	796.35	81.99B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.50	53.23B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	374.30	42.34B	5.76B	514.49M	1.10B	4.4813

Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-06-26	Resumed	H.C. Wainwright	Buy
Oct-03-25	Initiated	Leerink Partners	Outperform
Sep-09-25	Initiated	BTIG Research	Buy
Dec-09-21	Initiated	Siebert Williams Shank	Buy
Jun-02-21	Initiated	Daiwa Securities	Buy
Mar-15-21	Initiated	Needham	Buy
Mar-03-21	Reiterated	H.C. Wainwright	Buy
Feb-25-21	Initiated	Piper Sandler	Overweight
Dec-07-20	Initiated	H.C. Wainwright	Buy
Jul-27-20	Initiated	Cantor Fitzgerald	Overweight
Feb-12-20	Initiated	China Renaissance	Buy
Feb-11-20	Initiated	Jefferies	Buy

View All

Novabridge Biosciences Adr Stock (NBP) Latest News

Oct 12, 2026

3 Promising Penny Stocks With Market Caps Up To $200M - Simply Wall Street

Oct 12, 2026

Oct 06, 2026

NBP Q4 2025 Earnings: Loss Per Share Misses Widely, Yet Shares Edge HigherEarnings Trend Analysis - https://www.dars.gov.et/

Oct 06, 2026

Sep 21, 2026

NovaBridge Biosciences (NBP) CMO trades newly vested shares - Stock Titan

Sep 21, 2026

NBP Q4 2025 Earnings: Loss Per Share Misses Consensus by a Wide MarginRetail Earnings Report - dars.gov.et

Sep 21, 2026

NBP Q4 2025 Earnings: Loss Per Share Misses Consensus by a Wide MarginRevenue Beat Analysis - www.dars.gov.et

Sep 21, 2026

NBP Q4 2025 Earnings: Loss Per Share Misses Consensus by a Wide MarginEarnings Call Transcript - dars.gov.et

Sep 21, 2026

Sep 11, 2026

NovaBridge Biosciences (NBP) officer sells shares to cover RSU tax withholding - Stock Titan

Sep 11, 2026

Sep 08, 2026

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director - GlobeNewswire Inc.

Sep 08, 2026

Director removed in shareholder vote at NovaBridge Biosciences (NBP) - Stock Titan

Sep 08, 2026

Sep 03, 2026

NovaBridge Biosciences (NBP) Q4 2025 Earnings: Wider-Than-Expected Loss of -$0.29 Per ADS; Shares Up 0.56%Low Estimate Range - dars.gov.et

Sep 03, 2026

Sep 02, 2026

NovaBridge Biosciences EVP Claire Xu disposes of $2,592 of NBP stock By Investing.com - Investing.com UK

Sep 02, 2026

Sep 01, 2026

NovaBridge Biosciences EVP Claire Xu disposes of $2,592 of NBP stock - Investing.com

Sep 01, 2026

NovaBridge Biosciences (NBP) EVP sells 3,282 shares after stock-unit exercise - Stock Titan

Sep 01, 2026

Aug 30, 2026

NovaBridge Biosciences (NBP) Slips 2.65% to $1.84 as Key Support HoldsSupply Zone - dars.gov.et

Aug 30, 2026

NovaBridge Biosciences (NBP) Slips 2.65% to $1.84 as Key Support HoldsPre-Earnings Momentum - dars.gov.et

Aug 30, 2026

NovaBridge Biosciences (NBP) Slips 2.65% to $1.84 as Key Support HoldsPut Flow Alert - dars.gov.et

Aug 30, 2026

Aug 18, 2026

NovaBridge (NBP) Latest Results Brief: Profit Per Share Falls Below Its Benchmark in Latest Trading; Post-Earnings Trading: The Stock Ends Down 2.07% in the Current UpdateDividend Increase Stocks - careplusvn.com

Aug 18, 2026

NovaBridge (NBP) Latest Results Brief: Profit Per Share Falls Below Its Benchmark in Latest Trading; Post-Earnings Trading: The Stock Ends Down 2.07% in the Current UpdateGross Profit Margin - dars.gov.et

Aug 18, 2026

Aug 14, 2026

NovaBridge Biosciences (NBP) Advances 3.16% to $1.96, Testing Key Resistance at $2.06Insider Selling Alerts - dars.gov.et

Aug 14, 2026

NovaBridge Biosciences (NBP) Advances 3.16% to $1.96, Testing Key Resistance at $2.06Linear Regression - dars.gov.et

Aug 14, 2026

Aug 05, 2026

NovaBridge Biosciences (NBP) Holds Support at $1.56 After 0.61% DipCovered Call Trade - dars.gov.et

Aug 05, 2026

Jul 27, 2026